The global Celecoxib market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Celecoxib volume and value at global level, regional level and company level. From a global perspective, this report represents overall Celecoxib market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Celecoxib in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Celecoxib manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Shire
Teva
Mylan
Chengdu Suncadia Pharmaceuticals
Jiangsu Chiatai Qingjiang Pharmaceutical
Anhui Heyi Chemical
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
50mg Celecoxib
100mg Celecoxib
200mg Celecoxib
400mg Celecoxib

Segment by Application
Rheumatoid Arthritis
Osteoarthritis
Acute Pain
Musculoskeletal Pain
Others